Effects of chronic oral l-arginine administration on the l-arginine/NO pathway in patients with peripheral arterial occlusive disease or coronary artery disease: l-Arginine prevents renal loss of nitrite, the major NO reservoir

Amino Acids

Volumn 47, Issue 9, 2015, Pages 1961-1974

  Schneider, Jessica Y ^a   Rothmann, Sabine ^a   Schröder, Frank ^a   Langen, Jennifer ^b   Lücke, Thomas ^b   Mariotti, François ^c   Huneau, Jean François ^c   Frölich, Jürgen C ^a   Tsikas, Dimitrios ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c CENTRE MAURICE HALBWACHS   (France)

Author keywords

Cardiovascular disease; Nitric oxide; Nitrite; Prostacyclin; Renal carbonic anhydrase; Thromboxane

Indexed keywords

ARGININE; CARBONATE DEHYDRATASE; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; NITRITE; PLACEBO; NITRIC ACID DERIVATIVE;

AGED; AMINO ACID BLOOD LEVEL; AMINO ACID URINE LEVEL; ARTICLE; CHRONIC DRUG ADMINISTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG TOLERANCE; ENZYME ACTIVITY; FEMALE; GROWTH HORMONE DEFICIENCY; HUMAN; LIPID DIET; MALE; METABOLIC PARAMETERS; NITRATE METABOLISM; NITRATE TO NITRITE MOLAR RATIO; NITRATE URINE LEVEL; NITRITE URINE LEVEL; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROTEIN DIET; SUPPLEMENTATION; TREATMENT DURATION; URINARY EXCRETION; URINE LEVEL; ADULT; KIDNEY PROXIMAL TUBULE; METABOLISM; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; RANDOMIZED CONTROLLED TRIAL; URINE;

ADULT; AGED; ARGININE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; KIDNEY TUBULES, PROXIMAL; MALE; MIDDLE AGED; NITRATES; NITRIC OXIDE; NITRITES; PERIPHERAL ARTERIAL DISEASE;

EID: 84940459588     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-015-2031-0     Document Type: Article

References (55)

1. Aamand R, Dalsgaard T, Jensen FB, Simonsen U, Roepstorff A, Fago A (2009) Generation of nitric oxide from nitrite by carbonic anhydrase: a possible link between metabolic activity and vasodilation. Am J Physiol Heart Circ Physiol 297:H2068-H2074
2. Achan V, Broadhead M, Malaki M, Whitley G, Leiper J, MacAllister R, Vallance P (2003) Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase. Arterioscler Thromb Vasc Biol 23:1455-1459
3. Ahmetaj-Shala B, Kirkby NS, Knowles R, Al'Yamani M, Mazi S, Wang Z, Tucker AT, Mackenzie L, Armstrong PC, Nüsing RM, Tomlinson JA, Warner TD, Leiper J, Mitchell JA (2015) Evidence that links loss of cyclooxygenase-2 with increased asymmetric dimethyl arginine: novel explanation of cardiovascular side effects associated with anti-inflammatory drugs. Circulation 131:633-642
4. Bode-Böger SM (2006) Effect of arginine supplementation on NO production in man. Eur J Clin Pharmacol 62:91-99
5. Bode-Böger SM, Böger RH, Creutzig A, Tsikas D, Gutzki FM, Alexander K, Frölich JC (1994) l-arginine infusion decreases peripheral arterial resistance and inhibits platelet aggregation in healthy humans subjects. Clin Sci 87:303-310
6. Bode-Böger SM, Böger RH, Alfke H, Heinzel D, Tsikas D, Creutzig A, Alexander K, Frölich JC (1996) l-Arginine induces nitric oxide-dependent vasodilation in patients with critical limb ischemia. A randomized, controlled study. Circulation 93:85-90
7. Bode-Böger SM, Böger RH, Löffler M, Tsikas D, Brabant G, Frölich JC (1999) l-Arginine stimulates NO-dependent vasodilation in healthy humans - effects of somatostatin pretreatment. J Invest Med 47:43-50
8. Böger RH (2004) Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, explains the "l-arginine paradox" and acts as a novel cardiovascular risk factor. J Nutr 134:2842S-2847S
9. Böhmer A, Gambaryan S, Tsikas D (2014) Human blood samples lack nitric oxide synthase activity. Platelets. doi: 10.3109/09537104.2014.974024
10. Brosnan ME, Brosnan JT (2004) Renal arginine metabolism. J Nutr 134:2791S-2895S
11. Chobanyan-Jürgens K, Schwarz A, Böhmer A, Beckmann B, Gutzki FM, Michaelsen JT, Stichtenoth DO, Tsikas D (2012) Renal carbonic anhydrases are involved in the reabsorption of endogenous nitrite. Nitric Oxide 26:126-131
12. Fitzgerald DJ, Fitzgerald GA (2013) Historical lessons in translational medicine: cyclooxygenase inhibition and P2Y12 antagonism. Circ Res 112:174-194
13. Förstermann U, Sessa WC (2012) Nitric oxide synthases: regulation and function. Eur Heart J 33:829-837
14. Gladwin MT, Raat NJ, Shiva S, Dezfulian C, Hogg N, Kim-Shapiro DB, Patel RP (2006) Nitrite as a vascular endocrine nitric oxide reservoir that contributes to hypoxic signaling, cytoprotection, and vasodilation. Am J Physiol Heart Circ Physiol 291:H2026-H2035
15. Hu SD, Li XL, Rezaei R, Meininger CJ, McNeal CJ, Wu G (2015) Safety of long-term dietary supplementation with l-arginine in pigs. Amino Acids 47:925-936
16. Innocenti A, Vullo D, Scozzafava A, Supuran CT (2008) Carbonic anhydrase inhibitors: inhibition of mammalian isoforms I-XIV with a series of substituted phenols including paracetamol and salicylic acid. Bioorg Med Chem 16:7424-7428
17. Kanno K, Hirata Y, Emori R, Ohta K, Eguchi S, Imai T, Marumo F (1992) l-Arginine infusion induces hypotension and diuresis/natriuresis with concomitant increased urinary excretion of nitrite/nitrate and cyclic GMP in humans. Clin Exp Pharmacol Physiol 19:619-625
18. Kayacelebi AA, Willers J, Pham VV, Hahn A, Schneider JY, Rothmann S, Frölich JC, Tsikas D (2015a) Plasma homoarginine, arginine, asymmetric dimethylarginine and total homocysteine interrelationships in rheumatoid arthritis, coronary artery disease and peripheral artery occlusion disease. Amino Acids. doi: 10.1007/s00726-015-1915-3
19. Kayacelebi AA, Langen J, Weigt-Usinger K et al (2015b) Biosynthesis of homoarginine (hArg) and asymmetric dimethylarginine (ADMA) from acutely and chronically administered free l-arginine in humans. Amino Acids. doi: 10.1007/s00726-015-2012-3
20. Keimer R, Stutzer FK, Tsikas D, Troost R, Gutzki FM, Frölich JC (2003) Lack of oxidative stress during sustained therapy with isosorbide dinitrate and pentaerythrityl tetranitrate in healthy humans: a randomized, double-blind crossover study. J Cardiovasc Pharmacol 41:284-292
21. Kielstein A, Tsikas D, Galloway GP, Mendelson JE (2007) Asymmetric dimethylarginine (ADMA) - a modulator of nociception in opiate tolerance and addiction? Nitric Oxide 17:55-59
22. Lachmuth JY (2007) The APAV pilot study. l-Arginine in patients with peripheral arterial occlusive disease. PhD thesis. Hannover Medical School, Hannover. http://d-nb.info/991618793/34
23. Langen J, Kayacelebi AA, Beckmann B, Weight-Usinger K, Carmann C, Hörster I, Lilienthal E, Richter-Unruh, Tsikas D, Lücke T (2015) Homoarginine (hArg) and asymmetric dimethylarginine (ADMA) in short stature children without and with growth hormone deficiency: hArg and ADMA are involved differently in growth in the childhood. Amino Acids
24. Lundberg JO, Govoni M (2004) Inorganic nitrate is a possible source for systemic generation of nitric oxide. Free Radic Biol Med 37:395-400
25. Lundberg JO, Gladwin MT, Ahluwalia A, Benjamin N, Bryan NS, Butler A, Cabrales P, Fago A, Feelisch M, Ford PC, Freeman BA, Frenneaux M, Friedman J, Kelm M, Kevil CG, Kim-Shapiro DB, Kozlov AV, Lancaster JR Jr, Lefer DJ, McColl K, McCurry K, Patel RP, Petersson J, Rassaf T, Reutov VP, Richter-Addo GB, Schechter A, Shiva S, Tsuchiya K, van Faassen EE, Webb AJ, Zuckerbraun BS, Zweier JL, Weitzberg E (2009) Nitrate and nitrite in biology, nutrition and therapeutics. Nat Chem Biol 5:865-869
26. Lüneburg N, Xanthakis V, Schwedhelm E, Sullivan LM, Maas R, Anderssohn M, Riederer U, Glazer NL, Vasan RS, Böger RH (2011) Reference intervals for plasma l-arginine and the l-arginine:asymmetric dimethylarginine ratio in the Framingham Offspring Cohort. J Nutr 141:2186-2190
27. Mariotti F, Petzke KJ, Bonnet D, Szezepanski I, Bos C, Huneau JF et al (2013) Kinetics of the utilization of dietary arginine for nitric oxide and urea synthesis: insight into the arginine-nitric oxide metabolic system in humans. Am J Clin Nutr 97:972-979
28. März W, Meinitzer A, Drechsler C, Pilz S, Krane V, Kleber ME, Fischer J, Winkelmann BR, Böhm BO, Ritz E, Wanner C (2010) Homoarginine, cardiovascular risk, and mortality. Circulation 122:967-975
29. Moncada S, Higgs A (1993) The l-arginine-nitric oxide pathway. N Engl J Med 329:2002-2012
30. Ohrem HL, Schornick E, Kalivoda A, Ognibene R (2014) Why is mannitol becoming more and more popular as a pharmaceutical excipient in solid dosage forms? Pharm Dev Technol 19:257-262
31. Pilz S, Meinitzer A, Gaksch M, Grübler M, Verheyen N, Drechsler C, Hartaigh BÓ, Lang F, Alesutan I, Voelkl J, März W, Tomaschitz A (2015) Homoarginine in the renal and cardiovascular systems. Amino Acids. doi: 10.1007/s00726-015-1993-2
32. Rassaf T, Feelisch M, Kelm M (2004) Circulating NO pool: assessment of nitrite and nitroso species in blood and tissues. Free Radic Biol Med 36:413-422
33. Rothmann S (2009) Pilot study on the effects of l-arginine in patients with coronary artery disease after angioplasty and method development for the determination of DMA in plasma as PFB derivative. PhD Thesis, Hannover Medical School, Hannover. http://d-nb.info/1007632712/34
34. Shi W, Meininger CJ, Haynes TE, Hatakeyama K, Wu G (2004) Regulation of tetrahydrobiopterin synthesis and bioavailability in endothelial cells. Cell Biochem Biophys 41:415-433
35. Sütö T, Losonczy G, Qiu C, Hill C, Samsell L, Ruby J, Charon N, Venuto R, Baylis C (1995) Acute changes in urinary excretion of nitrite + nitrate do not necessarily predict renal vascular NO production. Kidney Int 48:1272-1277
36. Tajiri K, Myakawa H, Izumi N, Marumo F, Sato C (1995) Systemic hypotension and diuresis by l-arginine in cirrhotic patients with ascites: role of nitric oxide. Hepatology 22:1430-1435
37. Tousoulis D, Briasoulis A, Papageorgiou N, Tsioufis C, Tsiamis E, Toutouzas K, Stefanadis C (2011) Oxidative stress and endothelial function: therapeutic interventions. Recent Pat Cardiovasc Drug Discov 6:103-114
38. Tousoulis D, Papageorgiou N, Briasoulis A, Androulakis E, Charakida M, Tsiamis E, Stefanadis C (2012) Conflicting effects of nitric oxide and oxidative stress in chronic heart failure: potential therapeutic strategies. Heart Fail Rev 17:65-79
39. Tsikas D (1998) Application of gas chromatography-mass spectrometry and gas chromatography-tandem mass spectrometry to assess in vivo synthesis of prostaglandins, thromboxane, leukotrienes, isoprostanes and related compounds in humans. J Chromatogr B 717:201-245
40. Tsikas D (2000) Simultaneous derivatization and quantification of the nitric oxide metabolites nitrite and nitrate in biological fluids by gas chromatography/mass spectrometry. Anal Chem 72:4064-4072
41. Tsikas D (2008) A critical review and discussion of analytical methods in the l-arginine/nitric oxide area of basic and clinical research. Anal Biochem 379:139-163
42. Tsikas D (2015) Circulating and excretory nitrite and nitrate: their value as measures of nitric oxide synthesis, bioavailability and activity is inherently limited. Nitric Oxide 45:1-3
43. Tsikas D, Kayacelebi AA (2014) Do homoarginine and asymmetric dimethylarginine act antagonistically in the cardiovascular system? Circ J 78:2094-2095
44. Tsikas D, Böger RH, Sandmann J, Bode-Böger SM, Frölich JC (2000a) Endogenous nitric oxide synthase inhibitors are responsible for the l-arginine paradox. FEBS Lett 478:1-3
45. Tsikas D, Gutzki FM, Böhme M, Fuchs I, Frölich JC (2000b) Solid- and liquid-phase extraction for the gas chromatographic-tandem mass spectrometric quantification of 2,3-dinor-thromboxane B2 and 2,3-dinor-6-oxo-prostaglandin F1 alpha in human urine. J Chromatogr A 885:351-359
46. Tsikas D, Schubert B, Gutzki FM, Sandmann J, Frölich JC (2003) Quantitative determination of circulating and urinary asymmetric dimethylarginine (ADMA) in humans by gas chromatography-tandem mass spectrometry as methyl ester tri (N-pentafluoropropionyl) derivative. J Chromatogr B 798:87-99
47. Tsikas D, Gutzki FM, Stichtenoth DO (2006) Circulating and excretory nitrite and nitrate as indicators of nitric oxide synthesis in humans: methods of analysis. Eur J Clin Pharmacol 62(Suppl 13):51-59
48. 15N]nitrite enrichment and concentration in urine by gas chromatography mass spectrometry as pentafluorobenzyl derivatives. Anal Chem 82:2585-2587
49. Tsikas D, Wolf A, Mitschke A, Gutzki FM, Will W, Bader M (2010b) GC-MS determination of creatinine in human biological fluids as pentafluorobenzyl derivative in clinical studies and biomonitoring: inter-laboratory comparison in urine with Jaffé, HPLC and enzymatic assays. J Chromatogr B 878:2582-2592
50. Tsikas D, Niemann J, Flentje M, Schwarz A, Tossios P (2014) N-Acetylcysteine (NAC) inhibits renal nitrite and nitrate reabsorption in healthy subjects and in patients undergoing cardiac surgery: risk of nitric oxide (NO) bioavailability loss by NAC? Int J Cardiol 177:30-33
51. Tsikas D, Pham VV, Suchy MT, van de Ree MA, Huisman MV, Frölich JC, Princen HM, DALI-Study Group (2015) No effects of atorvastatin (10 or 80 mg/day) on nitric oxide, prostacyclin, thromboxane and oxidative stress in type 2 diabetes mellitus patients of the DALI study. Pharmacol Res 94:1-8
52. van der Zwan LP, Davids M, Scheffer PG, Dekker JM, Stehouver CDA, Teerlink T (2013) l-Homoarginine and arginine are antagonistically related to blood pressure in an elderly population: the Hoorn study. J Hypertens 31:1114-1123
53. West SG, Likos-Krick A, Brown P, Mariotti F (2005) Oral l-arginine improves hemodynamic responses to stress and reduces plasma homocysteine in hypercholesterolemic men. J Nutr 135:212-217
54. Wu G, Bazer FW, Davis TA, Kim SW, Li P, Marc Rhoads J et al (2009) Arginine metabolism and nutrition in growth, health and disease. Amino Acids 37:153-168
55. Yang Y, Wu ZL, Jia SC, Dahanayaka S, Feng S, Meininger CJ, McNeal CJ, Wu G (2015) Safety of long-term dietary supplementation with l-arginine in rats. Amino Acids. doi: 10.1007/s00726-015-1992-3